Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000028

President and CEO acquired 57,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 1 in the form +57,500 221,367 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +169,100 169,100 D
Loading xslF345X05/wk-form4_1736198480.xml…